Skip to main content
Have a personal or library account? Click to login
Trial of Immune Globulin in Infant Botulism Cover

Trial of Immune Globulin in Infant Botulism

Open Access
|Feb 2006

Abstract

A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by type B toxin) was conducted at the California Department of Health Services, Richmond, CA; National Botulism Surveillance and Reference Laboratory, CDC and P, Atlanta; and Division of Biostatistics, University of California, Berkeley.
Language: English
Page range: 13 - 13
Published on: Feb 1, 2006
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.